Skip to main content
NIH funding notice RFA-DA-24-063

HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed)

Closed on February 1, 2024.

Posted
July 19, 2023
Close date
February 1, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,126,154 in first-year total cost, median $716,226.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 IXR-N (A2)]3

Most frequent institutions

  1. UNIVERSITY OF FLORIDA1
  2. UNIVERSITY OF MINNESOTA1
  3. UNIVERSITY OF WASHINGTON1
Competing awards under RFA-DA-24-063 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Development of computational and AI/ML tools to accelerate discovery of vaccines and antibodies against nitazenes and fentanyl analogs1R01DA061769-01PRAVETONI, MARCOUNIVERSITY OF WASHINGTON, WA$637,128ZDA1
2024Pharmacological targeting of nascent modulators of opioid signaling1R01DA061771-01MARTEMYANOV, KIRILL A.UNIVERSITY OF FLORIDA, FL$772,800ZDA1
2024Neurotensin receptor 1 as a novel target for opioid use disorder and discovery of new small molecule probes1R01DA061773-01OLSON, STEVEN HSLOSKY, LAUREN MUNIVERSITY OF MINNESOTA, MN$716,226ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.